BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 19449339)

  • 1. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
    Braam SR; Passier R; Mummery CL
    Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
    Dambrot C; Passier R; Atsma D; Mummery CL
    Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic stem cells for cardiomyogenesis.
    Habib M; Caspi O; Gepstein L
    J Mol Cell Cardiol; 2008 Oct; 45(4):462-74. PubMed ID: 18775434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review of basic studies about the cardiac stem cell and regenerative medicine].
    Tamura Y; Fukuda K
    Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
    Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
    Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte differentiation from embryonic and adult stem cells.
    Passier R; Mummery C
    Curr Opin Biotechnol; 2005 Oct; 16(5):498-502. PubMed ID: 16099156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte differentiation of human induced pluripotent stem cells.
    Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
    Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
    Steel D; Hyllner J; Sartipy P
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.
    Yokoo N; Baba S; Kaichi S; Niwa A; Mima T; Doi H; Yamanaka S; Nakahata T; Heike T
    Biochem Biophys Res Commun; 2009 Sep; 387(3):482-8. PubMed ID: 19615974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct generation of pluripotent stem cells from differentiated somatic cells].
    Li L; Guan W; Ma Y; Li H; Bai X; Gong X
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1695-701. PubMed ID: 19149179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of human embryonic stem cell technologies to drug discovery.
    Sartipy P; Björquist P; Strehl R; Hyllner J
    Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progenitor cell therapy for heart disease.
    Gonzales C; Pedrazzini T
    Exp Cell Res; 2009 Nov; 315(18):3077-85. PubMed ID: 19747911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.
    Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW
    Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cardiac stem cells.
    Barile L; Messina E; Giacomello A; Marbán E
    Prog Cardiovasc Dis; 2007; 50(1):31-48. PubMed ID: 17631436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.